1. Home
  2. ARW vs ALKS Comparison

ARW vs ALKS Comparison

Compare ARW & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARW
  • ALKS
  • Stock Information
  • Founded
  • ARW 1935
  • ALKS 1987
  • Country
  • ARW United States
  • ALKS Ireland
  • Employees
  • ARW N/A
  • ALKS N/A
  • Industry
  • ARW Electronic Components
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARW Technology
  • ALKS Health Care
  • Exchange
  • ARW Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • ARW 5.9B
  • ALKS 5.4B
  • IPO Year
  • ARW N/A
  • ALKS 1991
  • Fundamental
  • Price
  • ARW $103.68
  • ALKS $33.21
  • Analyst Decision
  • ARW Hold
  • ALKS Buy
  • Analyst Count
  • ARW 4
  • ALKS 13
  • Target Price
  • ARW $121.25
  • ALKS $39.50
  • AVG Volume (30 Days)
  • ARW 597.6K
  • ALKS 1.7M
  • Earning Date
  • ARW 05-01-2025
  • ALKS 04-30-2025
  • Dividend Yield
  • ARW N/A
  • ALKS N/A
  • EPS Growth
  • ARW N/A
  • ALKS 3.47
  • EPS
  • ARW 7.29
  • ALKS 2.17
  • Revenue
  • ARW $27,923,324,000.00
  • ALKS $1,557,632,000.00
  • Revenue This Year
  • ARW N/A
  • ALKS N/A
  • Revenue Next Year
  • ARW $8.02
  • ALKS $4.37
  • P/E Ratio
  • ARW $14.23
  • ALKS $15.10
  • Revenue Growth
  • ARW N/A
  • ALKS N/A
  • 52 Week Low
  • ARW $101.78
  • ALKS $22.90
  • 52 Week High
  • ARW $137.80
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • ARW 41.80
  • ALKS 43.58
  • Support Level
  • ARW $103.48
  • ALKS $33.22
  • Resistance Level
  • ARW $109.05
  • ALKS $34.45
  • Average True Range (ATR)
  • ARW 2.47
  • ALKS 0.98
  • MACD
  • ARW 0.15
  • ALKS -0.21
  • Stochastic Oscillator
  • ARW 22.71
  • ALKS 7.78

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: